APA (7th ed.) Citation

NK, A., JI, G., CL, H., JWS, W., A, O., S, M., . . . GP, A. (2026). The impact of pectin supplementation on systemic inflammation pathways, gut microbiome, and metabolic health in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A study protocol for a randomised controlled trial. PloS one, 21(7), e0352397. https://doi.org/10.1371/journal.pone.0352397

Chicago Style (17th ed.) Citation

NK, Al-Tameemi, et al. "The Impact of Pectin Supplementation on Systemic Inflammation Pathways, Gut Microbiome, and Metabolic Health in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Study Protocol for a Randomised Controlled Trial." PloS One 21, no. 7 (2026): e0352397. https://doi.org/10.1371/journal.pone.0352397.

MLA (9th ed.) Citation

NK, Al-Tameemi, et al. "The Impact of Pectin Supplementation on Systemic Inflammation Pathways, Gut Microbiome, and Metabolic Health in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Study Protocol for a Randomised Controlled Trial." PloS One, vol. 21, no. 7, 2026, p. e0352397, https://doi.org/10.1371/journal.pone.0352397.